Nexium (Esomeprazole)

Esomeprazole irreversibly inhibits the gastric H+/K+ ATPase (proton pump) in parietal cells, which is the final step in acid secretion. By blocking this enzyme, it markedly reduces both basal and stimulated gastric acid production, allowing the gastric pH to rise and damaged tissue to heal.

The specific dose of Nexium is determined by the prescribing clinician based on the patient’s condition, severity, and renal or hepatic function. Healthcare professionals should follow local prescribing guidelines and adjust the regimen as needed for each individual.

The safety of esomeprazole in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the Nexium product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and necessary import documentation.

Esomeprazole is the S‑enantiomer of omeprazole and generally provides more consistent acid suppression with a slightly longer duration of action. Compared with other PPIs, it may achieve faster healing of erosive lesions, but clinical outcomes are similar when used at appropriate doses.

Store Nexium at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from moisture and direct light, and ensure the container is sealed until use to maintain sterility.

Nexium is supplied as a sterile intravenous solution and is administered by a healthcare professional through an IV line. The infusion rate and duration are determined by the prescriber and should follow institutional protocols for intravenous drug delivery.

Serious adverse events, although rare, include Clostridioides difficile‑associated colitis, severe allergic reactions such as anaphylaxis, and electrolyte disturbances like hypomagnesemia. Patients should be monitored for signs of infection, allergic response, or unexplained muscle cramps and weakness.

Nexium is contraindicated in patients with known hypersensitivity to esomeprazole or any component of the formulation. Caution is advised for individuals with severe hepatic impairment, and it should be avoided in patients taking medications that require an acidic gastric environment for absorption unless clinically justified.